首页> 美国卫生研究院文献>BioMed Research International >Application of the Subtractive Genomics and Molecular Docking Analysis for the Identification of Novel Putative Drug Targets against Salmonella enterica subsp. enterica serovar Poona
【2h】

Application of the Subtractive Genomics and Molecular Docking Analysis for the Identification of Novel Putative Drug Targets against Salmonella enterica subsp. enterica serovar Poona

机译:减法基因组学和分子对接分析在鉴定针对肠炎沙门氏菌亚种的新型推定药物靶标中的应用。肠血清

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The emergence of novel pathogenic strains with increased antibacterial resistance patterns poses a significant threat to the management of infectious diseases. In this study, we aimed at utilizing the subtractive genomic approach to identify novel drug targets against Salmonella enterica subsp. enterica serovar Poona strain ATCC BAA-1673. We employed in silico bioinformatics tools to subtract the strain-specific paralogous and host-specific homologous sequences from the bacterial proteome. The sorted proteome was further refined to identify the essential genes in the pathogenic bacterium using the database of essential genes (DEG). We carried out metabolic pathway and subcellular location analysis of the essential proteins of the pathogen to elucidate the involvement of these proteins in important cellular processes. We found 52 unique essential proteins in the target proteome that could be utilized as novel targets to design newer drugs. Further, we investigated these proteins in the DrugBank databases and 11 of the unique essential proteins showed druggability according to the FDA approved drug bank databases with diverse broad-spectrum property. Molecular docking analyses of the novel druggable targets with the drugs were carried out by AutoDock Vina option based on scoring functions. The results showed promising candidates for novel drugs against Salmonella infections.
机译:具有增加的抗药性模式的新型致病菌株的出现对传染病的管理构成了重大威胁。在这项研究中,我们旨在利用减性基因组方法来确定针对肠沙门氏菌亚种的新型药物靶标。肠血清型Poona菌株ATCC BAA-1673。我们在计算机生物信息学工具中采用了从细菌蛋白质组中减去菌株特异性旁系同源序列和宿主特异性同源序列的方法。使用基本基因数据库(DEG)进一步精炼分类的蛋白质组,以鉴定病原细菌中的基本基因。我们对病原体的必需蛋白进行了代谢途径和亚细胞定位分析,以阐明这些蛋白在重要细胞过程中的参与。我们在目标蛋白质组中发现了52种独特的必需蛋白,这些蛋白可以用作设计新药的新靶标。进一步,我们在DrugBank数据库中研究了这些蛋白质,根据FDA批准的具有多种广谱特性的药物库数据库,其中11种独特的必需蛋白显示出可药用性。 AutoDock Vina选件基于评分功能对新型可药物靶向药物进行了分子对接分析。结果表明,抗沙门氏菌感染的新药有望出现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号